feed,title,long_url,short_url
Benzinga,Novartis' Rare Blood Disorder Therapy Aces Second Late-Stage Trial,https://benzinga.com/general/biotech/22/12/30006517/novartis-rare-blood-disorder-therapy-aces-second-late-stage-trial,https://da.gd/GsFM7
